Hot Topics Items
Long-lasting effects of cancer can plague patients for years after they complete their treatments. In this study, researchers sought to measure which problems plagued patients the most and for the longest time.
Distress screening at pivotal points in care helps nurses identify which patients need additional support as they cope with their disease and treatments.
Is it safe to use hair dyes concurrently with chemotherapy?
Transitions from one stage of cancer care to another are pivotal points of vulnerability for patients. The most significant point comes at the end of treatment, as patients face life forever changed.
How should a fibrin overgrowth on an internal catheter be managed when there is no blood return from the implanted port?
Listening to music or audiobooks has a profound impact on postoperative pain perception in children. The benefit is increased when the patients are allowed to choose their own music or stories.
How much more toxicity and myelosuppression has been associated with gemcitabine (Gemzar) when it is infused over periods longer than 30 minutes?
Many patients place too high a value on the effectiveness of tumor markers in demonstrating their posttreatment status. Even after offering a detailed explanation of the true worth of these tests, the author's patient still wants to know, "Are you going to order my tumor markers?"
How men perceive their role within their family dynamic or social circles may impact how they respond to a cancer diagnosis. Often they retreat or shut down, further challenging the efforts of their oncology care providers and loved ones to help them cope.
This emerging role is leading nurses toward more comprehensive patient care, improved community outreach, and a stronger voice to advocate for patients.
To access additional digital issues, please click here.
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- Epigenetic signatures differentiate triple negative breast cancers
- Novel drug approved for multiple myeloma
- Radiation therapy used most often for prostate cancer regardless of decision-making factors
- Precise risk assessment for gastric and breast cancers among CDH1 gene mutation carriers may improve genetic counseling
- Farydak (panobinostat) now FDA-approved for multiple myeloma
- ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer
- Urine test could help to guide treatment of bladder cancer
- Multiple studies are exploring whether e-cigarettes help smokers quit or continue smoking
- Study identifies reasons for ibrutinib discontinuation in patients with chronic lymphocytic leukemia
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|